Trillium Therapeutics (TRIL)
NASDAQ:TRIL
US Market
Holding TRIL?
Track your performance easily

Trillium Therapeutics (TRIL) Ownership - Who Owns Trillium Therapeutics?

0 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value
Jun 09, 2021
Robert Uger
Chief Scientific Officer
xxxxxxxxxxxxx
May 13, 2021
Skvarka Jan
President & Ceo,director
xxxxxxxxxxxxx
Feb 10, 2021
Robert Uger
Chief Scientific Officer
xxxxxxxxxxxxx
Jan 13, 2021
Robert Uger
Chief Scientific Officer
xxxxxxxxxxxxx

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value

FAQ

Who Owns Trillium Therapeutics (TRIL)?
Currently, no data Available
What percentage of Trillium Therapeutics (TRIL) stock is held by institutional investors?
Currently, no data Available
What percentage of Trillium Therapeutics (TRIL) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Trillium Therapeutics (TRIL)?
Currently, no data Available
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
    What am I Missing?
    Make informed decisions based on Top Analysts' activity
    Know what industry insiders are buying
    Get actionable alerts from top Wall Street Analysts
    Find out before anyone else which stock is going to shoot up
    Get powerful stock screeners & detailed portfolio analysis